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Using quantitative receptor autoradiography, [3HJD-Ala-t~-Leu-enkephalin (DADL) and [~H]naloxonc binding were studicd in rat 
striatum and striatal projection areas (globus pallidus (GP) and substantia nigra pars reticulata (SN~)) after unilateral striatal kainic 
acid lesions, p H ] D A D L  and [~H]naloxone binding were each examined by two methods. Initially, [3H]DADI. binding was performed 
in 50 mM Tris-HCl (pH 7.4), 3(./ mM NaCI, 3 mM manganese acetate and 2 j~M GTP: pH]naloxone binding was carried out in 50 mM 
Tris-HCl (pH 7.4) and 100 mM NaCI. Subsequent studies were carried out in 150 mM Tris-HCl (pH 7.4) and cither P H I D A D L  plus 
500 nM morphiceptin (to block [~H]DADL binding to mu receptors) or pH]naloxone plus iII nM delta receptor peptide (to block 
[~H]naloxone hinding to delta receptors). At one and eight weeks in the lesioned striatum, [~H]DADL binding was reduced by 70c,;- 
and 82c>;, respectively, when compared to the control side. [~H]Naloxone binding was reduced by 35~4 and 20(; - . In GP and SN~, 
[~H]DADL binding was reduced by 31% and 41 ¢:'f, respectively, at one week and 27% and 2654 at eight weeks. I~H]Naloxone binding 
was reduced 19(,: in GP at eight weeks. A parsimonious explanation of these results is that opiate binding sites arc located on presyn- 
aptic terminals of striatal efferent fibers ko globus pallidus and substantia nigra pars reticulata as well as on local striatal axon collate- 
rals. Since opiate pcptides have recently been found to coexist with G A B A  in some striatal neurons, opiate peptides may play a role in 
striatal function by controlling G A B A  relcase from striatal efferent fibers. It is possible that pallidal and nigral opiatc binding could be 
utilized as a marker for striatal tcrminals. 
1NTR()DUCTION 
Neurons and presynaptic terminals in the striatum 
contain high concentrations of enkephalin-like im- 
munoreactivity ~2L~.ls,27,as,5~. There are also high lev- 
els of enkephalin in the lateral globus pallidus 
(Gp)s.9.11 13,27,as,53 and some is present in the sub- 
stantia nigra pars reticulata (SNr)12.13. lmmunohisto- 
chemical studies suggest that the enkephalin in GP 
and SN, is located primarily in presynaptic termi- 
nals 12.as. The peptide is released from these terminals 
after electrical stimulation of caudate nucleus 24. Af- 
ter striatal lesions or deafferentation, enkephalin lev- 
els in GP and SNr fall markedly s,9,11,13,as. Taken to- 
gether, this evidence suggests that there is a major 
enkephalinergic pathway from the striatum to the GP 
and a lesser pathway to SNr. 
Despite this evidence for an enkephalinergic stria- 
topallidal and striatonigral pathway in rat, only low 
levels of both mu and delta opiate receptors have 
been found in the GP and SNr~,~'.w->,al,51. In con- 
trast, high levels of mu and delta opiate receptors 
have been observed in striatum ~,~.r,2~,22,41.51. Some 
striatal opiate receptors appear to be localized on the 
axon terminals of dopaminergic and serotonergic 
striatal afferent fibers>,39 and may function to con- 
trol dopamine and serotonin release. However, the 
role of opiates and opiate receptors in striatal func- 
tion and output is largely unknown. We have meas- 
ured opiate receptors in the striatum and the primary 
striatal projection areas after destruction of striatal 
neurons with kanic acid. 
METHODS 
Male Sprague-Dawley rats weighing 150-200 g 
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were anesthetized with 7 mg/kg xylazine and 
100 mg/kg ketamine (i.p.). Kainic acid lesions were 
made according to our previously described meth- 
od 38,42. Kainic acid (Sigma), 0.1 M, adjusted to 
pH 7.0 with HC1, was applied iontophoretically into 
the right striatum of these rats by passing negative 
current (5 ~A) in 500 ms on/500 ms off pulses for 5 
min through a glass micropipette tip with an inner di- 
ameter of 50/~m. Angled injections from 30 ° forward 
of vertical passing through prefrontal cortex were 
made using a David Kopf small animal stereotaxic 
device. The pipette tip was placed 2.0 mm anterior, 
3.0 mm lateral and 4.2 mm ventral to Bregma with 
the incisor bar 5 mm above the ear bars (AP 
+ 8.0 mm, ML + 3.0 mm, DV + 1.0 ram) accord- 
ing to the atlas of K6nig and Klippel 2s. 
In initial studies, rats were decapitated 7-10 days 
after the striatal lesion, the brains were quickly re- 
moved, mounted on microtome chucks with Lipshaw 
frozen embedding medium, and frozen at -20 °C. 
Twenty -j~m thick coronal sections of the brains were 
cut in a cryostat (Lipshaw) and thaw-mounted onto 
detergent cleaned, gelatin-coated microscope slides. 
Slides were kept frozen at -20 °C overnight. The 
next day, serial sections through the lesion, globus 
pallidus and substantia nigra were washed twice for 5 
rain each in cold buffer and then blown dry in a 
stream of cool air. Sections were incubated with 
[3H]naloxone (1-5 nM) in 50 mM Tris HCI (pH 7.4) 
and 100 mM NaCI at 4 °C for 1 h to preferentially la- 
bel mu opiate receptors, or with pH]D-Ata-D-Leu- 
enkephalin (DADL) (1-8 riM) in 50 mM Tris HC1, 
30 mM NaCI, 3 mM manganese acetate and 2 ~M 
GTP at 20 °C for 30 min according to the method of 
Lewis et al. 29. The slides were then given six 20-s 
washes with 50 mM Tris HCI, pH 7.4 at 4 °C, dried. 
mounted in an X-ray cassette with 6-14 calibrated 
standards and tritium-sensitive film (Ultrofilm 3H, 
LKB). The film was exposed for 3 -6  weeks at 4 °C 
and developed in D19, for 3 rain at 20 °C, fixed, wash- 
ed and dried. 
Films were analyzed using a spot densitometer -~s. 
Eight to ten measurements of optical density were 
made over each region of interest, as well as each 
standard and film background. The optical densities 
(ODs) produced by regions of interest were com- 
pared to the ODs produced by the standards and the 
film background. A computer-generated polynomial 
regression analysis of the standard curve was used 1o 
calculate the amount of radioactivity m a given area 
of interest. The total amount of ligand bound to each 
area of interest was calculated from the specific activ- 
ity of the ligand and the amount of radioactivity in the 
tissue. Specific binding in each area of interest was 
calculated by subtracting from the w~tal binding the 
amount of ligand bound to the region in sections incu- 
bated with excess (1 × 10 ¢, M) ctorphme (defined 
as non-specific binding). The number (Bmax) and 
affinity (K d) of receptors were calculated by Eadic- 
Hofstee analyses of dose-response curves from auto- 
radiographs of sections taken through the region of 
interest. 
At the concentrations examined (1-8 nM), sub- 
stantial variations in specific binding were observed 
between various brain regions. Although non-specif- 
ic binding was relatively uniform throughout the tis- 
sue section, the specific to non-specific ratios varied 
considerably. In the striatum, the 'nonpatch" areas 
had a specific to non-specific binding ratio of 3:1 for 
[.~H]naloxone and 10:1 for [-~H]DADL; in globus pal- 
lidus, the ratio was 3.4:1 for [-~H]naloxone binding 
and 5:1 for [3H]DADL; in substantia nigra pars retic- 
ulata, the ratio was 4.5:1 for [-~H]naloxone binding 
and 3.5:1 for [3H]DADL. 
Selected sections were postfixed over paraformal- 
dehyde vapors and stained with cresvl violet to assure 
that the lesions did not extend into the globus palli- 
dus. Sections were also analyzed ~v computer-as- 
sisted methods -~: to measure the approximate size of 
the striatal lesions. 
The incubation conditions described above label 
mu and delta receptors relatively selectively and the 
various ion and nucleotide concentrataons were used 
to maximize the number of bindine sites labeled. It 
was also considered important to study opiate recep- 
tors using drugs which would preferentially block del- 
ta receptor binding during [3H]naloxone binding 
studies and mu receptor binding during [3H]DADI_ 
binding studies. These assays used different buffer 
and incubation conditions from the first assays. It was 
ascertained that 10 nM delta receptor peptide t, 
would block 80-90% of [3H]DADL binding but only 
a 20-30% of [3H]naloxone binding. Likewise. it was 
determined that a 500 nM concentration of morphi- 
ceptin 6 would block 80-90% of [-3H]naloxone bind- 
ing but only 10-20% of [3HIDADL binding. 
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Additional animals were lesioned with kainate as 
described above, allowed to survive for 8 weeks, the 
animals decapitated and the brains removed, sec- 
tioned and prepared for autoradiography. Sections 
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were incubated in 1-6 nM [-~H]naloxone, 10 nM del- 
ta receptor peptide and 150 mM Tris HC1 buffer 
(pH 7.4) for l h at 4 °C. Alternate sections to those 







Fig. 1. Opiate receptor binding one week after a striatal kainatc lesion. A - C :  [SH]-~-Ala-D-Leu-cnkephalin binding to sections 
through the striatal lesion, lateral globus pallidus and substantia nigra, respectively. Binding was performed in the presencc of 5 nM 
[SHIDADL, 50 mM Tris-HCl (pH 7.4), 30 mM NaCI, 3 mM manganese acetate and 2 uM GTP: D-F :  [3tt]naloxonc binding to brain 
sections was performed in the presence of 5 nM pH]naloxone. 50 mM Tris-HCI (pH 7.4) and 100 mM NaCI. I). E and F are sections 
serially' adjacent to A, B and C. respectively. Each of these photographs was printed individually to optimize the appearance of recep- 
tors at each level. Thus, quantitative densitometric comparisons cannot be extrapolated directly from the visual images. GP, Globus 
pallidus; MT, Medial terminal nucleus of the accessory optic tract: SNr, Substantia nigra pars reticulata. 
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[3H]DADL,  500 nM morphicept in  and 150 mM Tris 
HCI buffer (pH 7.4) for 1 h at 4 °C. Af te r  incuba- 
tion, slides were washed 6 t imes in cold 50 mM Tris 
HC1 (pH 7.4) for 20 s each wash. The slides were 
then dr ied in a s t ream of coot air and exposed to 1,31- 
trofilm 3H (LKB) for 6 weeks.  Recep to r  numbers  
and affinities were then de te rmined  as above.  
RESULTS 
Autorad iograms  of [3H]DADL and [3H]naloxone 
binding de te rmined  by both methods  are shown in 
Figs. 1 and 3. The distr ibution of binding in cortex 
and str iatum was quite distinctive depending  upon 
the l igand used. This was true independent  of the in- 
cubat ion procedure .  Nevertheless ,  the different in- 
cubation condit ions brought  out differences in recep- 
tor  distr ibution.  [3H]DADL binding was highest in 
layers II,  I l I  and VI of cortex using ei ther  technique.  
In str iatum, [3H]DADL binding was relat ively uni- 
form but,  using the initial incubation condit ions,  
dense 'patches '  of binding were readi ly observed sim- 
ilar to that seen with [3H]naloxone binding. 'Pa tches '  
were virtually absent  when [3H]DADL binding was 
pe r fo rmed  in the presence of morphicept in .  Cort ical  
[3H]naloxone binding was highest in in termedia te  
layers of cortex. In str iatum, dense patches of opia te  
receptors  with lesser concentra t ions  in the back- 
ground were evident .  For both ligands, binding was 
low in globus pall idus and substantia nigra pars  retic- 
ulata. A consistent feature in the midbrain  with both 
ligands was a dense strip of binding in the medial  nu- 
cleus of the accessory optic tract along the medial  as- 
pect of nigra, in this study, nei ther  the opiate  recep- 
tors in patches,  nor in the medial  nucleus were sys- 
tematical ly analyzed because there were not enough 
serial sections for d o s e - r e s p o n s e  curves to be reh- 
able in these areas. 
Inspection of the autoradiogralns  from the first set 
of animals one week after lesioning revealed a loss of 
[3H]DADL binding in the str iatum. GP and SNr ipsi- 
lateral  to the lesion (Fig. IA- - ( ' ) .  [-q-l]Naloxone 
binding appeared  to be decreased in the lesion but 
not at distant sites (Fig. I D - F ) .  These observat ions  
were confirmed by quanti tat ive densitometr~ I see 
Table I). Area  measurements  of the lesion size in the 
striatum at mult iple levels indicated that.  on average,  
40~/c of the head of the caudate  was des t royed  by  the 
lesion. 
Receptor  binding in each animal was analyzed by 
Eadie-Hofs tee  plots of binding at 4--~ concentra t ions  
of each ligand in sections through each structure In 
the initial exper iment ,  there  were significant reduc- 
tions in the number  of [3H]DADL binding sites in the 
lesion (67% decrease.  P < 0.001 ~ and the ipsilateral 
GP (30~ decrease ,  P < 0.011 and SN~ ~41cA de- 
TABLE 1 
Opiate receptors one week after unilateral striatal lesions 
Binding was carried out as described in the text using the first set of incubation conditions, values represent the average of 6-9 animals 
_+ S.E.M 
Region [-~H]DA DL binding [3H]naloxone binding 
B .... (fmol/mg K d (nM) Lesioned/ B ..... (fmol/mg K,t (nM) l,esioned/ 
protein) control protein) control 
(× 100) (× tOOi 
Striatum (n = 9) 
Lesioned 211 ± 43** 3.4 + 0.7 30 214 ± 10" 1.2 _+ (1.3 ~5 
Control 701 ± 109 3.7 _+ 0.4 331 ± 30 1.5 ±_ 0~4 
Globus Pallidus (n = 9) 
Lesioned 1(t8 ± 11" 2.3 ± 1.0 69 218 + 20 1.9 .+ {1.5 
Control t57 + 10 2.0 ± 0.7 273 ± 43 1.7 2:(1.4 
80 
Substantia Nigra (n = 6) 
Lesioned 213 +__ 54** 4.2 ± 1.2 59 361 ± 100 2.3 ~_ 1 I 89 
Control 363 +_ 99 4.3 .+ t).6 406 ± 68 2.1 .+ 1_2 
* P < 0.01 by two-tailed paired t-test. 










ToII~J~ B1 N% 'MN G ) 
~ .0 nM 0 ~ .  
5 10 15 20 25 
B O U N D / F R E E  
O 
Z 







4 0 0  ( H - N A L O X O N E  B I N D I N G )  
300 
200 o ' ~ K  D 2 .2  nM 
0 10 20 30 
B O U N D / F R E E  
r ~  
Z E  
o~ 
m ~  
C3 
r9 






SUBSTANTIA  NIGRA 
( 3 H - D A D L  B INDING)  
\• 
r-I" \ E:] 
G "\ K D 4 6  nM 
\ \  
' \  • (3 
~ K D 7  1 nM 
\ 
5 10 






..a ~ 100, 
¢o 50, 
GLOBUS PALLIDUS 




B O U N D / F R E E  
Fig. 2. Representanve  Eadie-Hofstee plots of pH]-D-Ala-D-Leu-enkephalin (DADL)  binding in various regions of rat brains one 
week after unilateral striatal kainate lesions, Serial sections of rat brain were incubated with 1-8 nM [3H]DADL or 1-5 nM [~H]na~ 
loxone as described in the methods.  Points represent  the mean of 8 densitometric readings taken from the area of interest on the auto- 
radiogram. Closed squares represent  values from the lesioned side and open squares represent  values from the unlesioned side. 
crease, P < 0.01) (Fig. 2, Table I). The only signifi- 
cant reduction in [3H]naloxone binding was a 36% 
decrease (P < 0.01) in the lesion. This decrease was 
significantly less than the decrease in p H ] D A D L  
binding in the same areas. There were no significant 
changes in the affinity of binding for either ligand in 
any of the areas measured. 
Using incubation procedures which included either 
delta receptor peptide or morphiceptin in assays of 
tissue sections from animals surviving 8 weeks post- 
lesion, changes in binding similar to those seen acute- 
ly (1 week) after striatal lesions were seen in stria- 
tum, globus pallidus and nigra (Fig. 3, Table II). 
Overall [3H]naloxone and [~H]DADL binding using 
this second incubation procedure was less than with 
the first assay (see Tables I and II) because of the dif- 
ferent ionic and nucleotide conditions and because of 
the cross inhibition of mu and delta sites. Again, the 
lesion size was about 40% of the head of the caudate. 
[3H]DADL binding was decreased 82% (P < 0.001) 
at the site of the lesion in striatum, 27% (P < 0.01) 
in globus pallidus and 26% (P < 0.02) in substantia 
nigra pars reticulata (Fig. 3A-C) .  [3H]Naloxone 
binding was decreased by 20%. (P < 0.02) in stria- 
turn, 19% (P < 0.05) in globus pallidus and non-sig- 
nificantly by 27%, in substantia nigra pars reticulata 
(Fig. 3D-F) .  In striatum, [3H]naloxone binding in 
the 'patches' was decreased dramatically at 8 weeks 
(but not quantified). This change in the patches was 
not observed at one week post lesion with either incu- 
bation method. 
DISCUSSION 
Striatal kainate lesions caused decreases in opiate 
binding locally in the stfiatum and distantly in the 
globus pallidus and substantia nigra of rats. The mag- 
nitude of the receptor changes in the striatal projec- 
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TABLE I1 
Opiate receptors eight weeks after unilateral striatal lesions 
Assays were as described in the text using the second set of incubation conditions. Values are the average ± S. E. M. l h e  number ol an- 
imals used for [3H]DADL binding in striatum, GP and SN r equaled 6, 6 and 5, respectively. The number Of animals used for [3H]nalox- 
one binding in striatum, GP and SN~ equaled 9, 9 and 8. respectively. 
Region [,¢H]DA DL binding 
B ....... (fmol/rng K~l (nM) 
protein) 
Striatum 
Lesioned 35 +_ 6 ~ 1.2 ± 0.3 
Control 195 _+ 24 2.2 ± 0.4 
[3 H]naloxone binding 
Lesioned/ B ...... (#nol/rng K,l (nM) Lesioned: 
control protein) contro/ 
(× 100) ! × 100~ 
74 L 8 ~ 2.1 ± 0.3 S0 
IN 9 2 ± 9  2 .0±1}3 
Globus Pallidus 
Lesioned 29 + 2 b 1.4 _+ 0.2 
Control 40 ± 2 2.1 ± 0.6 
55 ± 9 (~ 2.3 +_ I).,; S1 
73 68 ± 10 2.4 ± 1.2 
Substantia Nigra 
Lesioned 56 ± 10 c 
Control 76 _+ 12 
a p < 0.001 by two-tailed paired t-test. 
b p < 0.01 by two-tailed paired t-test. 
c p < 0.02 by two-tailed paired t-test. 
d p < 0.05 by two-tailed paired t-test. 
2.8 ± 0.8 
3.1 ± O.7 
74 101 ± 16 2.9 ± 0.~ 7~ 
139±28 4 2 £  1.~ 
tion areas averaged about  30%. consistent  with the 
size of the striatal lesion (which was about  40% of the 
body of the caudate) .  These  changes were similar to 
those found for known presynapt ic  markers  of stria- 
tal terminals  such as levels of G A B A  34. glutamic acid 
decarboxylase 4,t4 substance-p4, 25 and enkephal in  it- 
selfS, 9,11,48. These results differ from those that  have 
been found for markers  of postsynapt ic  receptors  af- 
ter striatal lesions 19.3°.38,46,47.5° In these studies.  
there  were local decreases in G A B A ,  benzodiaze-  
pine,  muscarinic cholinergic and dopamine  receptors  
while there  were  distant  increases in G A B A  and ben- 
zodiazepine  but  not  acetylcholine receptors3S,SL The  
la t ter  results were consistent  with the deve lopment  of 
postsynapt ic  receptor  supersensit ivity.  
In this study,  the findings suggested that opia te  
binding sites in globus pall idus and substant ia  nigra 
existed on str iatofugal presynapt ic  axon terminals .  
The results were consistent  with neurophysiological  
evidence that  enkephal ins  acted presynapt ical ly  on 
axon terminals  to inhibit  the release of o ther  neuro-  
transmitters3X.32 and with anatomical  studies showing 
the presynapt ic  localizat ion of opia te  receptors  in 
s t r ia tum and o ther  regions 1,3,33,39,44. It might be ar- 
gued that the local loss of opia te  binding seen after  
striatal lesions was consistent  with a postsynaptic  lo- 
cation of these binding sites in the str iatum. It should 
be r emembered ,  however ,  that striatal neurons have 
a vast number  of local recurrent  axon collaterals  2-40 
and local release of enkephal in  in the s t r ia tum has 
been demons t ra ted  after  striatat s t imulat ion 2t. Thus. 
the most parsimonius explanat ion for the results 
found in this s tudy is that  a substantial  por t ion of the 
opia te  binding sites in the str iatum, pal l idum and ni- 
gra are on presynapt ic  terminals  of striatal neurons.  
If this proves true. measurement  of opia te  binding 
might serve as a marker  for striatal  cell toss in animal 
studies and in human studies using posi t ron emission 
tomography.  
The difference in the binding of [3H]DADL and 
[3H]natoxone in the les ioned animals was intriguing. 
Nei ther  [3H]DADL binding nor [3H]naloxone bind- 
ing was absolutely selective for  del ta  and mu recep- 
tors and with each ligand there was a certain amount  
of labeling of o ther  receptor  subtypes 5. Two different 
binding assays were used to enhance selective label- 
ing to delta and mu receptors.  In  each case. the 
changes in opia te  binding after str iatal  lesions were 
more significant under  condit ions which favored 
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Fig. 3. Opiate receptor binding 8 weeks after a striatal kainate lesion. A-C: [3H]-i>-Ala-D-Leu-enkephalin binding to sections through 
the striatal lesion, globus pallidus and substantia nigra, respectively. Binding was performed in the presence of 4 nM [~H]DADL, 
15~) mM Tris HCI (pH 7.4) and 500 nM morphiceptin. D-F: [3H]naloxone binding to sections serially adjacent to those in A-C. Bind- 
ing was performed in the presence of 5 nM [3H]naloxone, 150 mM Tris HCI (pH 7.4) and 10 nM delta receptor pcptidc. Each of these 
photographs was printed individually to optimize the appearance of receptors at each level. Thus, quantitative dcnsitometric compari- 
sons can not be extrapolated directly from the visual images. Abbreviations as in Fig. 1. 
this observa t ion  was the long term changes seen in 
[3Hlnaloxone b ind ing  to the 'patches ' .  In this s tudy,  it 
was not  ascer ta ined  whe the r  the changes  in b ind ing  
to the +patches' involved pos tsynapt ic  receptor  
changes or long term degenera t ion  of striatal afferent  
fibers. Likewise,  the possibil i ty of receptor  loss due 
to t ransynapt ic  dendr i t ic  degene ra t ion  was not  evalu-  
ated. Transsynapt ic  degene ra t ion  of postsynapt ic  
28 
dendrites has been observed after decortications and 
nigrostriatai lesions20. Similar transsynaptic degener- 
ation could account for some of the binding changes 
seen in GP and SNr. Also, it should be noted that not 
all striatal opiate receptors are thought to be on the 
axon terminals of striatal neurons. Other investiga- 
tors have shown that some striatal opiate binding 
sites are on serotonin and dopamine striatal afferent 
terminals33, 39. Kappa receptor binding7,15 also was 
not assessed in this study but would be of interest 
since a subset of striatal neurons demonstrate dynor- 
phin-like immunoreactivity 49 and levels of dynorphin 
are high in substantia nigra pars reticulata27,45, 4~. 
The role of opiate peptides in striatal function and 
striatal output is unclear. A large percentage of stria- 
tal neurons show opiate-like immunoreactivity~2. A 
similarly large proportion of striatal neurons (ap- 
proximately 70%) demonstrate GAD-like immuno- 
reactivity indicating a high concentration of GABA 
neurons  in s t r ia tum 36. Recen t ly ,  n n m u n o c y t o c h e m i -  
cal doub le - l abe l ing  studies have  d e m o n s t r a t e d  a co- 
exis tence of  op ia te - l ike  and G A D - l i k e  i m m u n o r e a c -  
tivity 36. The  coex i s t ence  of  op ia te  pep t ides  in G A B A  
neurons  and the  p resynap t ic  loca l iza t ion  of  op ia te  re-  
ceptors  on  striatal  e f fe ren t  t e rmina l s  suggest  that  
striatal opia tes  may  func t ion  in par t  to cont ro l  
G A B A  re lease  presynapt ica l ly .  The  presynapt ic  con- 
trol of  G A B A  re lease  may be one  mechan i sm by 
which opia tes  affect  str iatal  funct ion  ~. 
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